VBS
VECTUS BIO FPO [VBS]
Healthcare · ASX Small Cap
$0.1950 +11.4%
Updated 14 Jul 2026 · Signals refresh every scan
Get alerts when VBS triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Pressing against the upper Bollinger Band — extended and may need to cool off
- Trading above both moving averages — the trend is your friend here
- Above-average volume (1.5x) on a green day — buyers stepping up
- Just broke above 20-day resistance — a level that was capping price, now cleared
- On a tear — up 39.3% over the last 5 days
- Beating the Small Ords index — relative strength of 1.40, so it's outpacing the pack
- Volatility is expanding fast — choppy price action, so buckle up
- Trading above the 200-day average — the long-term trend is on your side
- Critical cash runway (1.6 quarters)
- Very high P/S ratio (123.4x)
- Revenue in sharp decline (-99%)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (1 events)
- CANSLIM S: Tight float (40%)
- Sentiment is mixed — no strong consensus either way
- Strong long-term momentum — up 150% over the past year (excluding last month)
- Excellent risk-adjusted returns — Sharpe of 1.6 means strong gains without wild swings
- The bigger volume days are the up days — volume-weighted momentum is positive (2.42%/day)
- RBA hiking (-3pts)
- Dilution risk: technical breakout with recent capital raise
Risk Signals
- RSI is running hot — overbought territory, so expect some pullback risk
- Stochastic is stretched into overbought — could need a breather
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -99% — the top line is shrinking
Ask Scout AI about VBS
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE VBS Engages CHRS as Regulatory Agent for FDA Submissions
NONE Cleansing Notice
NONE Application for quotation of securities - VBS
Announcement tone +5pts
Recent ASX Announcements
| 2026-07-12 | VBS Engages CHRS as Regulatory Agent for FDA Submissions |
| 2026-06-26 | Cleansing Notice |
| 2026-06-26 | Application for quotation of securities - VBS |
| 2026-06-16 | CEO Investor Webinar |
| 2026-05-29 | Change in substantial holding |
Key Metrics
$11.1M
Market Cap
47K
Avg Volume
1.5x
Vol Ratio
$0.04 — $0.46
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 40% |
| L | Leader vs Laggard | pass | RS: 26 |
| I | Institutional Sponsorship | weak | Inst: 6% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
109 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track VBS and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required